Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

An Unusual Case of Acquired Hemophilia a and Factor XIII Consumption

Brett L. Houston, MD, Christine M. Cserti-Gazdewich, MD, Richard Ward, MBBS, Jean St. Louis, MD, Georges E. Rivard, MD, Jerome M. Teitel, MD, Michelle Sholzberg, MD

Blood (2015) 126 (23): 4701.

https://doi.org/10.1182/blood.V126.23.4701.4701

Published: 2015

Journal Articles

Treatment Of Serious Bleeds With a B-Domain Deleted Recombinant Porcine Sequence Factor VIII (OBI-1) In Patients With Acquired Hemophilia A: A Prospective Clinical Trial

Rebecca Kruse-Jarres, MD, MPH, Jean St. Louis, MD, Anne Greist, MD, Amy D. Shapiro, MD, Hedy Smith, MD PhD, Pratima Chowdary, MBBS, FRCP, FRCPath, Anja B Drebes, MRCP, FRCPath, Edward D. Gomperts, MD, Miranda Chapman, Min Mo, Aaron Novack, PhD, Heinrich D. Farin, MD

Blood (2013) 122 (21): 206.

https://doi.org/10.1182/blood.V122.21.206.206

Published: 2013

Journal Articles

Recombinant B-Domain Deleted Porcine Factor VIII (OBI-1) Safety and Efficacy in the Treatment of Acquired Hemophilia A: Interim Results.

Jean St. Louis, MD, Rebecca Kruse-Jarres, MD/MPH, Anne Greist, MD, Amy D. Shapiro, MD, Hedy Smith, MD PhD, Anja B Drebes, MRCP, FRCPath, Jay N. Lozier, MD, PhD, Edward D. Gomperts, MD

Blood (2012) 120 (21): 2224.

https://doi.org/10.1182/blood.V120.21.2224.2224

Published: 2012

Journal Articles

Ten-Year Canadian National Prospective Data On Utilization of Anti-Hemophilic Concentrates: Indications and Trends

Irwin Walker, MBBS, Aicha N Traore, MD, MSc, Alfonso Iorio, MD, PhD, Bruce Ritchie, MD, Nancy Heddle, MSc, Kathryn E Webert, MD, MSc, Jean St. Louis, MD, David Lillicrap, MD, Jerome M. Teitel, MD, Anthony K.C. Chan, MBBS, FRCPC, FRCPath

Blood (2012) 120 (21): 1186.

https://doi.org/10.1182/blood.V120.21.1186.1186

Published: 2012

Journal Articles

A Phase II Open-Label Study Evaluating Hemostatic Activity, Pharmacokinetics and Safety of Recombinant Porcine Factor VIII (OBI-1) in Hemophilia A Patients with Alloantibody Inhibitors Directed Against Human FVIII.

Johnny Mahlangu, MD, Tatiana A. Andreeva, MD, Donald Macfarlane, MD, PhD, Mark T. Reding, MD, Christopher Walsh, MD, Bruce Ritchie, MD, Nadia Ewing, MD, Craig M. Kessler, MD, Christine Kempton, MD, Edward Libby, MD, Nadezda Zozulya, MD, Amy D. Shapiro, MD, Jean St-Louis, MD, Indira Warrier, MD, W. Keith Hoots, MD, Ralph A. Gruppo, MD, Josef N. Mueksch, MD, MBA

Blood (2007) 110 (11): 783.

https://doi.org/10.1182/blood.V110.11.783.783

Published: 2007

NARROW

An Unusual Case of Acquired Hemophilia a and Factor XIII Consumption

Treatment Of Serious Bleeds With a B-Domain Deleted Recombinant Porcine Sequence Factor VIII (OBI-1) In Patients With Acquired Hemophilia A: A Prospective Clinical Trial

Recombinant B-Domain Deleted Porcine Factor VIII (OBI-1) Safety and Efficacy in the Treatment of Acquired Hemophilia A: Interim Results.

Ten-Year Canadian National Prospective Data On Utilization of Anti-Hemophilic Concentrates: Indications and Trends

A Phase II Open-Label Study Evaluating Hemostatic Activity, Pharmacokinetics and Safety of Recombinant Porcine Factor VIII (OBI-1) in Hemophilia A Patients with Alloantibody Inhibitors Directed Against Human FVIII.

Email alerts

ASH Publications

American Society of Hematology

An Unusual Case of Acquired Hemophilia a and Factor XIII Consumption

Treatment Of Serious Bleeds With a B-Domain Deleted Recombinant Porcine Sequence Factor VIII (OBI-1) In Patients With Acquired Hemophilia A: A Prospective Clinical Trial

Recombinant B-Domain Deleted Porcine Factor VIII (OBI-1) Safety and Efficacy in the Treatment of Acquired Hemophilia A: Interim Results.

Ten-Year Canadian National Prospective Data On Utilization of Anti-Hemophilic Concentrates: Indications and Trends

A Phase II Open-Label Study Evaluating Hemostatic Activity, Pharmacokinetics and Safety of Recombinant Porcine Factor VIII (OBI-1) in Hemophilia A Patients with Alloantibody Inhibitors Directed Against Human FVIII.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only